
Every month, Stanford Parkinson’s Community Outreach produces a list of Parkinson’s-related webinars and virtual meetings with speakers. Here’s our June 2023 list.
… Full Story>Every month, Stanford Parkinson’s Community Outreach produces a list of Parkinson’s-related webinars and virtual meetings with speakers. Here’s our June 2023 list.
… Full Story>People with Parkinson’s disease or parkinsonism have a much higher risk of hip and other fractures. The TOPAZ (Trial of Parkinson’s and Zoledronic Acid) study will test if zoledronate, an FDA-approved medication for osteoporosis (thinning of the bone), can prevent fractures in people with Parkinson’s disease, whether or not they have osteoporosis. Using zoledronate for this purpose is investigational. Continue reading for a summary of the study and to see if you are eligible to participate. You could receive $100 upon enrollment and $50 per year during the study.
… Full Story>“The doctor says my hearing’s fine, but he wants to check out your mumble.” (New Yorker Cartoon)
… Full Story>The American Parkinson Disease Association’s (APDA’s) A Closer Look blog is designed to educate, inform, and inspire you through a variety of topics and insights about Parkinson’s disease (PD). One way the APDA does that is through our Interview with APDA Researchers series within this blog so you can get a closer look at some of the dedicated APDA-funded researchers who are working tirelessly to understand this disease.
… Full Story>Too often health and medical news reporting is unreliable, at best – ten years ago one study found nearly 90% of all health news stories contained inaccurate information, and it’s only gotten more difficult since then to sort out the useful information from hype, advertisements, or genuinely fake news. In the effort to make their stories catch readers’ eyes, journalists frequently mistake, exaggerate, or spin reports. Often reporters also miss details that make all the difference when it comes to transforming research findings into useful medical treatment.
… Full Story>